6-Ethyl-3,4-dihydro-2H-pyran | 38614-16-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧杂环化合物
• 英文名称: 6-Ethyl-3,4-dihydro-2H-pyran
• 英文别名: 2-Ethyldihydropyran；6-ethyl-3,4-dihydro-2H-pyran；2-Ethyl-5.6-dihydro-4H-pyran
• CAS: 38614-16-3
• 化学式: C₇H₁₂O
• 分子量: 112.172
• InChiKey: KVTKURQAIMSVJE-UHFFFAOYSA-N

物化性质

• 沸点：
  130 °C
• 密度：
  0.887±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  6-Ethyl-3,4-dihydro-2H-pyran 在 三甲基氯硅烷 、 Benzyltriethylammonium borohydride 、 氧气 作用下， 以 二氯甲烷 为溶剂， 反应 7.5h， 以69%的产率得到heptane-1,5-diol
  参考文献：
  名称：

  烯醇醚与苄基三乙基氢硼化铵和三甲基氯硅烷的新颖而不同寻常的反应

  摘要：

  已发现苄基三乙基硼氢化铵-氯三甲基硅烷试剂体系在非常温和的反应条件下，与环状和环状烯醇醚1进行新颖而不同寻常的反应，分别分别高收率地分别生成二醇和醇2。

  DOI：

  10.1016/s0040-4039(00)60976-0
• 作为产物：
  描述：

  2-Ethyl-2-decyloxy-tetrahydropyran 、 磷酸 生成 6-Ethyl-3,4-dihydro-2H-pyran
  参考文献：
  名称：

  DELAUNAY J.; LEBOUC A.; RIOBE O., BULL. SOC. CHIM. FRANCE, 1979, PART 2, NO 9-10, 547-551

  摘要：

  DOI：

文献信息

• A novel and unusual reaction of enol ethers with banzyltriethylammonium borohydride and chlorotrimethylsilane
  作者：S. Baskaran、N. Chidambaram、N. Narasimhan、S. Chandrasekaran

  DOI：10.1016/s0040-4039(00)60976-0

  日期：1992.10

  Benzyltriethylammonium borohydride-chlorotrimethylsilane reagent system has been found to effect a novel and unusual reaction with cyclic and cyclic enol ethers 1 to give exclusively diols and alcohols 2 respectively in high yields, under very mild reaction conditions.

  已发现苄基三乙基硼氢化铵-氯三甲基硅烷试剂体系在非常温和的反应条件下，与环状和环状烯醇醚1进行新颖而不同寻常的反应，分别分别高收率地分别生成二醇和醇2。
• Alkene Hydrofunctionalization Reactions
  申请人：Sigman Matthew S.

  公开号：US20090069580A1

  公开（公告）日：2009-03-12

  A reductive cross coupling reaction process for functionalization of a nucleophilic alkene can be achieved. The nucleophilic alkene and a nucleophilic cross coupling partner compound can be reacted in the presence of an oxidizable alcohol and a suitable catalyst to form a reductive coupling product. Various additives can also be useful to refine the process such as by mitigating certain undesirable intermediates, facilitating specific site selectivity for various substitutions or reaction sites, etc. Chiral additives can be optionally used which act to provide asymmetric catalysis, e.g. allow for regioselective and stereoselective production of reductive coupling products. A reductive cross coupling pathway can include oxidizing the oxidizable alcohol to form a catalyst hydride. The nucleophilic alkene can be inserted into the catalyst hydride to form a catalyst-alkyl intermediate. Further, the catalyst-alkyl intermediate can be transmetallized with the nucleophilic cross coupling partner compound to form a transmetallated intermediate. The catalyst can be reductively eliminated to form the reductive coupling product and a reduced catalyst. Finally, the reduced catalyst can be oxidized under aerobic conditions, for example with oxygen, to form the oxidized catalyst and subsequent repetition through the cyclic pathway.

  可以实现对亲核烯烃进行官能化的还原型交叉偶联反应过程。在可氧化醇和适当的催化剂存在下，亲核烯烃和亲核交叉偶联配体化合物可以发生反应，形成还原型偶联产物。各种添加剂也可用于优化该过程，例如通过减轻某些不良中间体，促进特定位点的选择性取代或反应位点等。还可以选择性地使用手性添加剂，用于提供不对称催化作用，例如实现还原型偶联产物的区域选择性和立体选择性生产。还原型交叉偶联途径可以包括将可氧化醇氧化以形成催化剂氢化物。亲核烯烃可以插入催化剂氢化物中，形成催化剂烷基中间体。此外，催化剂烷基中间体可以与亲核交叉偶联配体化合物发生转金属化反应，形成一个转金属化中间体。催化剂可以发生还原消除反应，形成还原偶联产物和还原催化剂。最后，还原催化剂可以在氧气等气氛条件下氧化，形成氧化催化剂，并通过循环途径进行后续重复。
• COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS
  申请人：CHE Jianwei

  公开号：US20110053897A1

  公开（公告）日：2011-03-03

  Provided herein area novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity.

  本文提供了一种新型化合物、包含这些化合物的药物组合物以及使用这些化合物治疗或预防与异常或非调节Syk激酶活性有关的疾病或紊乱的方法。
• Modulators of ATP-Binding Cassette Transporters
  申请人：Ruah Sara S. Hadida

  公开号：US20110071206A1

  公开（公告）日：2011-03-24

  Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

  本发明的化合物及其药学上可接受的组合物可用作ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜导电调节因子（“CFTR”）。本发明还涉及使用本发明的化合物治疗ABC转运蛋白介导的疾病的方法。
• Fused substituted aminopyrrolidine derivative
  申请人：Takahashi Hisashi

  公开号：US20120108582A1

  公开（公告）日：2012-05-03

  A quinolone synthetic antibacterial agent having excellent properties as a medicine is provided, which has strong antibacterial activity not only to Gram-negative bacteria but also to Gram-positive cocci that have low sensitivity to quinolone antibacterial agents, and which exhibits high safety and excellent pharmacokinetics. A compound represented by the formula (I) or a salt thereof, or a hydrate thereof. Specifically, a quinolone derivative of the formula (I) wherein substituents R6 and R7 taken together with the carbon atoms to which they are bonded form a cyclic structure which may contain an oxygen atom as a ring constituent atom, the cyclic structure forming a 5-4, 5-5, or 5-6 fused bicyclic pyrrolidinyl substituent, the substituent being bonded to a quinolone mother skeleton Q containing a pyridobenzoxazine structure.

  提供了一种具有极好药物特性的喹诺酮合成抗菌剂，其不仅对革兰氏阴性菌具有强烈的抗菌活性，而且对对喹诺酮抗菌剂敏感度较低的革兰氏阳性球菌也具有强烈的抗菌活性，并表现出高安全性和优异的药代动力学特性。该化合物由式(I)或其盐或水合物表示，具体而言，是式(I)的喹诺酮衍生物，其中取代基R6和R7与它们所连接的碳原子一起形成一个环状结构，该环状结构可能包含一个氧原子作为环状成分原子，该环状结构形成一个5-4、5-5或5-6融合的双环吡咯烷基取代物，该取代物与含有吡啶苯并噁嗪结构的喹诺酮母骨架Q连接。